Compare OMF & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OMF | ICLR |
|---|---|---|
| Founded | 1920 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 8.2B |
| IPO Year | 2013 | 2001 |
| Metric | OMF | ICLR |
|---|---|---|
| Price | $57.59 | $113.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | $66.75 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 1.3M | 745.0K |
| Earning Date | 05-01-2026 | 04-30-2026 |
| Dividend Yield | ★ 7.32% | N/A |
| EPS Growth | ★ 54.72 | N/A |
| EPS | ★ 6.56 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $68.08 | N/A |
| Revenue Next Year | $6.90 | N/A |
| P/E Ratio | ★ $8.75 | $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $43.45 | $66.57 |
| 52 Week High | $71.93 | $211.00 |
| Indicator | OMF | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 62.01 | 57.10 |
| Support Level | $55.80 | $95.75 |
| Resistance Level | $58.02 | $114.75 |
| Average True Range (ATR) | 1.30 | 4.78 |
| MACD | 0.70 | 1.71 |
| Stochastic Oscillator | 93.58 | 88.13 |
OneMain Holdings Inc is a consumer finance company providing loan products to customers through its branch network and the internet. The company provides personal loan products; offers credit cards; offers optional credit insurance and others; offers a customer-focused financial wellness program, and acquisitions and dispositions of assets and businesses. It provides origination, underwriting, and servicing of personal loans to non-prime customers. The company operates in single reportable segment Consumer and Insurance which originates and services personal loans and auto finance loans, offer credit cards, and provide optional credit and non-credit insurance and other optional products through its branch and central operations, as well as digital platform.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.